Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074
Status:
Completed
Trial end date:
2017-10-13
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the effect of multiple doses of the UGT
inhibitor valproic acid on the single-dose pharmacokinetics of BIIB074. The secondary
objectives of this study are to evaluate the safety and tolerability of BIIB074 when
administered alone and when coadministered with the UGT inhibitor valproic acid and to
evaluate the effect of the UGT inhibitor valproic acid on the PK of the M13, M14, and M16
metabolites of BIIB074.